SMAD6 variants enriched in CHD, BAV, or skull malformation have been well described previously (Calpena et al., 2020; Gillis et al., 2017; Jin et al., 2017; Kloth et al., 2019; Lelieveld et al., 2016). Here, SMAD6 is linked to coronary artery disorder.